The U.S. Food and Drug Administration (FDA) is set to announce a new warning that the Johnson & Johnson COVID-19 vaccine is linked to a rare autoimmune disease. The FDA is planning to release a new warning that the Johnson & Johnson COVID-19 vaccine is linked to a rare autoimmune disease called Guillain-Barré syndrome. Guillain-Barré syndrome is an autoimmune disorder in which complications on one's immune system leads to damage to the nerves and weakness to the muscles. In rare cases, the disease can lead to permanent nerve damage, or death. Comparatively, just 12.8 million Americans have been vaccinated with the J&J shot due to a number of setbacks for the firm.

Source: Daily Mail July 12, 2021 17:59 UTC